Our study shows that a combination therapy comprising TCM and standard biomedical treatment is more effective in reducing clinical symptom and TCM syndrome scores, as well as the scores of the DLQI, EI, and IL-37 levels in patients with rosacea. The gene discussed is IL37; the disease is rosacea.